摘要
目的:探究新Bobath技术联合血塞通片在出血性脑卒中患者中的治疗效果。方法:选择2020年2月—2023年9月枣庄市峄城区人民医院收治的90例出血性脑卒中患者为研究对象,采用密闭信封法将其分为对照组和研究组,各45例。两组均口服血塞通片,对照组采用常规运动训练治疗,研究组在对照组基础上联合新Bobath技术治疗。比较两组步行稳定性、运动功能及生命质量。结果:治疗3个月后,研究组Tinetti步态评估量表、Fugl-Meyer运动功能评估量表、脑卒中生命质量测定量表评分均高于对照组,差异均有统计学意义(P<0.05)。结论:应用新Bobath技术联合血塞通治疗出血性脑卒中患者,可提高患者步行稳定性及运动功能,从而改善其生命质量。
Objective:To explore the application effect of new Bobath technology combined with Xuesaitong Tablet on treatment in patients with hemorrhagic stroke.Methods:A total of 90 hemorrhagic stroke patients treated in Zhaozhuang Yicheng District People’s Hospital from February 2020 to September 2023 were selected as the study objects.They were divided into a control group and a research group by sealed envelope method,with 45 cases in each group.Both groups were given oral Xuesaitong Tablets,the control group combined with routine exercise training treatment,and the research group combined with the new Bobath technology treatment on the basis of the control group.The walking stability,motor function and quality of life of the two groups were compared..Results:After 3 months of treatment,the scores of Tinetti Gait Assessment Scale,Fugl-Meyer Motor Function Assessment Scale,Quality of Life Instruments for Chronic Diseases-Stroke in the research group were higher than those in the control group,with statistical significance(P<0.05).Conclusion:The new Bobath technology combined with Xuesaitong Tablet in teatment of patients with hemorrhagic stroke can improve the walking stability and motor function and improve their quality of life.
作者
郭金龙
GUO Jinlong(Department of Neurosurgery,Zaozhuang Yicheng District People’s Hospital,Zaozhuang 277300,China)
出处
《中国伤残医学》
2024年第14期5-7,15,共4页
Chinese Journal of Trauma and Disability Medicine
